Arama Sonuçları - Lothar Bernd Zimmerhackl

  • Gösterilen 1 - 19 sonuçlar arası kayıtlar. 19
Sonuçları Daraltın
  1. 1
    Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)

    Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS) Yazar: Johanna Scheiring, Sharon Andreoli, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Clinical Course and the Role of Shiga Toxin–Producing<i>Escherichia coli</i>Infection in the Hemolytic‐Uremic Syndrome in Pediatric Patients, 1997–2000, in Germany and Austria: A Prospective Study

    Clinical Course and the Role of Shiga Toxin–Producing<i>Escherichia coli</i>Infection in the Hemolytic‐Uremic Syndrome in Pediatric Patients, 1997–2000, in Germany and Austria: A P... Yazar: Angela Gerber, Helge Karch, Franz Allerberger, Hege M. Verweyen, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Enterohemorrhagic Escherichia coli in Human Infection: In Vivo Evolution of a Bacterial Pathogen

    Enterohemorrhagic Escherichia coli in Human Infection: In Vivo Evolution of a Bacterial Pathogen Yazar: Alexander Mellmann, Martina Bielaszewska, Lothar Bernd Zimmerhackl, Richard W. Prager, Dag Harmsen, H. Tschäpe, Helge Karch

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?

    Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm? Yazar: Martina Bielaszewska, Robin Köck, Alexander W. Friedrich, Christof von Eiff, Lothar Bernd Zimmerhackl, Helge Karch, Alexander Mellmann

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Disease recurrence in paediatric renal transplantation

    Disease recurrence in paediatric renal transplantation Yazar: Pierre Cochat, Sonia Fargue, Guillaume Mestrallet, Therese Jungraithmayr, Paulo César Koch Nogueira, Bruno Ranchin, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    The Pharmacokinetic-Pharmacodynamic Relationship for Total and Free Mycophenolic Acid in Pediatric Renal Transplant Recipients

    The Pharmacokinetic-Pharmacodynamic Relationship for Total and Free Mycophenolic Acid in Pediatric Renal Transplant Recipients Yazar: Lutz T. Weber, Maria Shipkova, Victor W. Armstrong, Natalie Wagner, Ekkehard Schütz, Otto Mehls, Lothar Bernd Zimmerhackl, Michael Oellerich, Burkhard Tönshoff

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome

    Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome Yazar: Lothar Bernd Zimmerhackl, Johannes Hofer, Gérard Cortina, Walter Mark, Reinhard Würzner, Therese Jungraithmayr, Gus Khursigara, Kay Oliver Kliche, Wolfgang Radauer

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Comparison of the Emit Immunoassay with HPLC for Therapeutic Drug Monitoring of Mycophenolic Acid in Pediatric Renal-Transplant Recipients on Mycophenolate Mofetil Therapy

    Comparison of the Emit Immunoassay with HPLC for Therapeutic Drug Monitoring of Mycophenolic Acid in Pediatric Renal-Transplant Recipients on Mycophenolate Mofetil Therapy Yazar: Lutz T. Weber, Maria Shipkova, Victor W. Armstrong, Natalie Wagner, Ekkehard Schütz, Otto Mehls, Lothar Bernd Zimmerhackl, Michael Oellerich, Burkhard Tönshoff

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

    Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae Yazar: Alejandra Rosales, Johannes Hofer, Lothar‐Bernd Zimmerhackl, Therese Jungraithmayr, Magdalena Riedl, Thomas Giner, Alexander Strasak, Dorothea Orth‐Höller, Reinhard Würzner, Helge Karch

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Eculizumab for Atypical Hemolytic–Uremic Syndrome

    Eculizumab for Atypical Hemolytic–Uremic Syndrome Yazar: Jens Nürnberger, Thomas Philipp, Oliver Witzke, Anabelle Opazo Saez, Udo Vester, Hideo A. Baba, Andreas Kribben, Lothar Bernd Zimmerhackl, Andreas Janecke, Mato Nagel, Michael Kirschfink

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.

    Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Th... Yazar: Lutz T. Weber, Maria Shipkova, T. Lamersdorf, P. D. Niedmann, M. Wiesel, A Mandelbaum, Lothar Bernd Zimmerhackl, Ekkehard Schütz, Otto Mehls, Michael Oellerich, Victor W. Armstrong, Burkhard Tönshoff

    Baskı/Yayın Bilgisi 1998
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register

    Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register Yazar: Barbara Wiedemann, Edith Schober, Thomas Waldhoer, J Koehle, Sarah E. Flanagan, Deborah Mackay, Elisabeth Steichen, Dagmar Meraner, Lothar‐Bernd Zimmerhackl, Andrew T. Hattersley, Sian Ellard, Sabine E. Hofer

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk

    Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk Yazar: Franz Allerberger, Alexander W. Friedrich, Katharina Grif, Manfred P. Dierich, Hans-Rirgen Dornbusch, Cristoph J. Mache, Edith Nachbaur, Michael Freilinger, Rieck Petra, Martin Wagner, Alfredo Caprioli, Helge Karch, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome

    Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome Yazar: Gema Ariceta, Nesrin Beşbaş, Sally Johnson, Diana Karpman, Daniel Landau, Christoph Licht, Chantal Loirat, Carmine Pecoraro, C. Mark Taylor, Nicole C. A. J. van de Kar, Johan Vandewalle, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Editorial
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

    Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome Yazar: Dorothea Orth‐Höller, Abdul Basit Khan, Asma Naim, Katharina Grif, Jens Brockmeyer, Helge Karch, Michael Joannidis, Simon J. Clark, Anthony J. Day, Sonja Fidanzi, Heribert Stoiber, Manfred P. Dierich, Lothar Bernd Zimmerhackl, Reinhard Würzner

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

    Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome Yazar: Johannes Hofer, Andreas Janecke, Lothar Bernd Zimmerhackl, Magdalena Riedl, Alejandra Rosales, Thomas Giner, Gérard Cortina, Carola J. Haindl, Barbara Petzelberger, Miriam Pawlik, Verena Jeller, Udo Vester, Bettina Gadner, Michael van Husen, Michael L. Moritz, Reinhard Würzner, Therese Jungraithmayr

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Screening for NPHS2 Mutations May Help Predict FSGS Recurrence after Transplantation

    Screening for NPHS2 Mutations May Help Predict FSGS Recurrence after Transplantation Yazar: Therese Jungraithmayr, Katrin Hofer, Pierre Cochat, Gil Chernin, Gérard Cortina, Sonia Fargue, Paul C. Grimm, Tanja Knueppel, Andreas Kowarsch, Thomas J. Neuhaus, Philipp Pagel, Karl Pfeiffer, Franz Schäfer, Ulf Schönermarck, Tomáš Seeman, Burkhard Toenshoff, Stefanie Weber, Michelle P. Winn, Johannes Zschocke, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Efficacy and Safety of Basiliximab in Pediatric Renal Transplant Patients Receiving Cyclosporine, Mycophenolate Mofetil, and Steroids

    Efficacy and Safety of Basiliximab in Pediatric Renal Transplant Patients Receiving Cyclosporine, Mycophenolate Mofetil, and Steroids Yazar: G. Offner, Burkhard Toenshoff, Britta Höcker, Manuela Krauss, M. Bulla, Pierre Cochat, Henry Fehrenbach, Wolfgang Fischer, M Foulard, Bernd Höppe, Peter F. Hoyer, Therese Jungraithmayr, Günter Klaus, Kay Latta, Heinz E. Leichter, Michael J. Mihatsch, Joachim Misselwitz, Carmen Montoya, Dirk E. Müller‐Wiefel, Thomas J. Neuhaus, Lars Pape, Uwe Querfeld, Christian Plank, D Schwarke, Simone Wygoda, Lothar Bernd Zimmerhackl

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

    Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome Yazar: Christophe Legendre, Christoph Licht, Petra Muus, Larry A. Greenbaum, Sunil Babu, Camille L. Bedrosian, Coralie Bingham, D.J. Cohen, Yahsou Delmas, K. Douglas, Frank Eitner, Thorsten Feldkamp, Denis Fouque, Richard R. Furman, Osama Gaber, Maria Herthelius, Maryvonne Hourmant, Diana Karpman, Yvon Lebranchu, Christophe Mariat, Jan Menne, Bruno Moulin, Jens Nürnberger, Masayo Ogawa, Giuseppe Remuzzi, Tristan Richard, Rébecca Sberro‐Soussan, Beth Severino, N. Sheerin, Antonella Trivelli, Lothar Bernd Zimmerhackl, Tim Goodship, Chantal Loirat

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: